BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen Q, Ding H, Zhou J, Zhao X, Zhang J, Yang C, Li K, Qiao M, Hu H, Ding P, Zhao X. Novel glycyrrhetinic acid conjugated pH-sensitive liposomes for the delivery of doxorubicin and its antitumor activities. RSC Adv 2016;6:17782-91. [DOI: 10.1039/c6ra01580h] [Cited by in Crossref: 20] [Cited by in F6Publishing: 1] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Zhang J, Du Z, Pan S, Shi M, Li J, Yang C, Hu H, Qiao M, Chen D, Zhao X. Overcoming Multidrug Resistance by Codelivery of MDR1-Targeting siRNA and Doxorubicin Using EphA10-Mediated pH-Sensitive Lipoplexes: In Vitro and In Vivo Evaluation. ACS Appl Mater Interfaces 2018;10:21590-600. [DOI: 10.1021/acsami.8b01806] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 6.8] [Reference Citation Analysis]
2 Sun L, Chu X, Liu C, Sheng L, Chen Z, Cheng K. Antiproliferative activity of ursolic acid/glycyrrhetinic acid-uracil/thymine hybrids. Med Chem Res 2019;28:892-9. [DOI: 10.1007/s00044-019-02344-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
3 Fan D, Yu J, Yan R, Xu X, Wang Y, Xie X, Liu C, Liu Y, Huang H. Preparation and Evaluation of Doxorubicin-Loaded Micelles Based on Glycyrrhetinic Acid Modified Gelatin Conjugates for Targeting Hepatocellular Carcinoma. Journal of Nanomaterials 2018;2018:1-13. [DOI: 10.1155/2018/8467169] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]